Patients Clinical trials fail in recruitment Clinical trials struggle in many areas, and significantly in recruitment.
Patients Towards a healthier world: Momentum in UK health system tran... In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.
Patients ASCO 26: War, disasters, policy compound cancer care challen... A Friday ASCO session highlighted the challenges faced by cancer patients in situations of geopolitical crisis, as presenters called for more support.
Patients If GLP-1s work too well, what happens next for metabolic dis... What happens if GLP-1s work too well?
Patients The cardio-renal-metabolic space and obesity as a chronic di... The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.
Patients Why biohackers are ditching vague health metrics Precision diagnostics enable targeted therapeutics.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
